Viral Shah, M.D.

Bio

Dr. Shah is a Professor of Medicine in the Division of Endocrinology & Metabolism and Director of Diabetes Clinical Research at the Center for Diabetes and Metabolic Diseases at Indiana University School of Medicine. His research focuses on improving glycemic control and reducing complications, with a special interest in fracture prevention, in people with type 1 diabetes (T1D). 

Dr. Shah has been the principal investigator for many clinical trials of diabetes technologies and therapeutics. He has been a part of many landmark research projects that led to FDA approval of newer devices and changed T1D management. Moreover, his interest in understanding the effect of diabetes on bone fragility had led to NIH-funded studies investigating the effects of long-standing T1D on bone structural and tissue material properties in older adults with T1D. 

Dr. Shah has served in many leadership positions such as steering committee member for T1D Exchange Clinic Registry (2016-2017), Chair-Elect, Diabetes Technology Interest Group (2022-2024) and 83^rd/84^th Scientific Session Planning Committee member (2022-2024) at the American Diabetes Association. He is the recipient of the prestigious AACE Rising Star in Endocrinology Award (2021), ADA Diabetes Technology Interest Group Award (2022), Diabetes Technology Society Leadership Award (2023) and Mary Tyler Moore, and S. Robert Levine, MD Excellence in Clinical Research Award from JDRF (2024).

He serves as the Editor-in-Chief for Clinical Diabetology, Senior Editor for the Endocrine Connections and on the Editorial Board for Diabetes Care and Journal of Diabetes Science and Technology. He is well published with over 170 research publications including original articles, invited reviews, editorials and book chapters.